Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).
https://news.vumc.org/2021/02/05/convalescent-plasma-improved-survival-in-covid-19-patients-with-blood-cancers/#new_tab
